No Cover Image

Conference Paper/Proceeding/Abstract 785 views

A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation

Matthew Hitchings Orcid Logo, Sue Chandler, Andrew Cunningham, Dean Harris Orcid Logo

Falk Foundation Symposium 217 West Meets East: Functional Meets Organic in Gastrointestinal Diseases

Swansea University Authors: Matthew Hitchings Orcid Logo, Dean Harris Orcid Logo

Abstract

Interest in the use of faecal microbiota transplantation (FMT) is steadily increasing since the approval of FMT in the management of recurrent clostridium difficile infections (rCDI) in 2014 by NICE and the explosion of international literature regarding the microbiome. Gut dysbiosis is considered t...

Full description

Published in: Falk Foundation Symposium 217 West Meets East: Functional Meets Organic in Gastrointestinal Diseases
Published: 2019
Online Access: http://www.falk-foundation-symposia.org/symposia-and-workshops/2019/?L=1
URI: https://cronfa.swan.ac.uk/Record/cronfa53365
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2020-01-27T13:30:33Z
last_indexed 2020-07-08T19:15:55Z
id cronfa53365
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2020-07-08T14:05:14.5413002</datestamp><bib-version>v2</bib-version><id>53365</id><entry>2020-01-27</entry><title>A National Survey of IBD Clinician&#x2019;s Perspectives on the Use of Faecal Microbiota Transplantation</title><swanseaauthors><author><sid>be98847c72c14a731c4a6b7bc02b3bcf</sid><ORCID>0000-0002-5527-4709</ORCID><firstname>Matthew</firstname><surname>Hitchings</surname><name>Matthew Hitchings</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>731533890c5123febe4f65dffd369f7b</sid><ORCID>0000-0003-2673-8946</ORCID><firstname>Dean</firstname><surname>Harris</surname><name>Dean Harris</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-01-27</date><deptcode>BMS</deptcode><abstract>Interest in the use of faecal microbiota transplantation (FMT) is steadily increasing since the approval of FMT in the management of recurrent clostridium difficile infections (rCDI) in 2014 by NICE and the explosion of international literature regarding the microbiome. Gut dysbiosis is considered to have a central role in the pathogenesis of inflammatory bowel disease (IBD). FMT as a treatment in IBD appears promising but is unproven. The aim of this survey was to assess the perceptions of clinicians in Wales potentially involved in patients who could benefit from the treatment of FMT.</abstract><type>Conference Paper/Proceeding/Abstract</type><journal>Falk Foundation Symposium 217 West Meets East: Functional Meets Organic in Gastrointestinal Diseases</journal><publisher/><keywords/><publishedDay>29</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-11-29</publishedDate><doi/><url>http://www.falk-foundation-symposia.org/symposia-and-workshops/2019/?L=1</url><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-07-08T14:05:14.5413002</lastEdited><Created>2020-01-27T11:13:44.4380333</Created><authors><author><firstname>Matthew</firstname><surname>Hitchings</surname><orcid>0000-0002-5527-4709</orcid><order>1</order></author><author><firstname>Sue</firstname><surname>Chandler</surname><order>2</order></author><author><firstname>Andrew</firstname><surname>Cunningham</surname><order>3</order></author><author><firstname>Dean</firstname><surname>Harris</surname><orcid>0000-0003-2673-8946</orcid><order>4</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2020-07-08T14:05:14.5413002 v2 53365 2020-01-27 A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation be98847c72c14a731c4a6b7bc02b3bcf 0000-0002-5527-4709 Matthew Hitchings Matthew Hitchings true false 731533890c5123febe4f65dffd369f7b 0000-0003-2673-8946 Dean Harris Dean Harris true false 2020-01-27 BMS Interest in the use of faecal microbiota transplantation (FMT) is steadily increasing since the approval of FMT in the management of recurrent clostridium difficile infections (rCDI) in 2014 by NICE and the explosion of international literature regarding the microbiome. Gut dysbiosis is considered to have a central role in the pathogenesis of inflammatory bowel disease (IBD). FMT as a treatment in IBD appears promising but is unproven. The aim of this survey was to assess the perceptions of clinicians in Wales potentially involved in patients who could benefit from the treatment of FMT. Conference Paper/Proceeding/Abstract Falk Foundation Symposium 217 West Meets East: Functional Meets Organic in Gastrointestinal Diseases 29 11 2019 2019-11-29 http://www.falk-foundation-symposia.org/symposia-and-workshops/2019/?L=1 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2020-07-08T14:05:14.5413002 2020-01-27T11:13:44.4380333 Matthew Hitchings 0000-0002-5527-4709 1 Sue Chandler 2 Andrew Cunningham 3 Dean Harris 0000-0003-2673-8946 4
title A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation
spellingShingle A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation
Matthew Hitchings
Dean Harris
title_short A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation
title_full A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation
title_fullStr A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation
title_full_unstemmed A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation
title_sort A National Survey of IBD Clinician’s Perspectives on the Use of Faecal Microbiota Transplantation
author_id_str_mv be98847c72c14a731c4a6b7bc02b3bcf
731533890c5123febe4f65dffd369f7b
author_id_fullname_str_mv be98847c72c14a731c4a6b7bc02b3bcf_***_Matthew Hitchings
731533890c5123febe4f65dffd369f7b_***_Dean Harris
author Matthew Hitchings
Dean Harris
author2 Matthew Hitchings
Sue Chandler
Andrew Cunningham
Dean Harris
format Conference Paper/Proceeding/Abstract
container_title Falk Foundation Symposium 217 West Meets East: Functional Meets Organic in Gastrointestinal Diseases
publishDate 2019
institution Swansea University
url http://www.falk-foundation-symposia.org/symposia-and-workshops/2019/?L=1
document_store_str 0
active_str 0
description Interest in the use of faecal microbiota transplantation (FMT) is steadily increasing since the approval of FMT in the management of recurrent clostridium difficile infections (rCDI) in 2014 by NICE and the explosion of international literature regarding the microbiome. Gut dysbiosis is considered to have a central role in the pathogenesis of inflammatory bowel disease (IBD). FMT as a treatment in IBD appears promising but is unproven. The aim of this survey was to assess the perceptions of clinicians in Wales potentially involved in patients who could benefit from the treatment of FMT.
published_date 2019-11-29T04:06:16Z
_version_ 1763753461520793600
score 11.01353

Similar Items